On June 16, 2017, UACT delivered a letter to the Chairman and Ranking Member of the US Senate Health, Education, Labor, and Pensions (HELP) Committee regarding the soon-to-be introduced comprehensive health care bill.  In the letter to Senators Lamar Alexander and Patty Murray, UACT urged the HELP committee to hold public hearings on how the GOP-led health care reform bill will affect cancer patients. As highlighted by Sen. Murray in a HELP Committee hearing on prescription drug prices held on Tuesday June 13, 2017, the bill (which is currently being negotiated in secret) at this point is slated to be introduced and voted on withoutRead More →

Time for cancer patients to come before corporate profits by Manon Ress, co founder and acting director of UACT First posted by MOHGA KAMAL-YANNI ON JUN 15TH, 2017 IN ACCESS TO MEDICINES, INEQUALITY, NON COMMUNICABLE DISEASES, UNIVERSAL HEALTH COVERAGE http://www.globalhealthcheck.org/?p=1973 On 26th Of May, the World Health Assembly adopted the long debated Resolution on Cancer Prevention and Control. This is an important step towards supporting countries to address this disease in order to achieve Universal Health Coverage (UHC). Cancers are a leading cause of morbidity and mortality worldwide, with approximately 14 million new cases and 8.2 million cancer-related deaths in 2012, 70% of which occurredRead More →

On May 31, 2017, World Health Assembly adopted a new resolution on the prevention and control of cancer.   UACT earlier wrote about the negotiations on the resolution here and here.  IP-Watch published a story about the resolution here.  A not quite final version of the text is here. The following are statements from four members of UACT:   Dr. Manon Ress, Founder and Acting Director, Union for Affordable Cancer Treatment (UACT) UACT was among 29 civil society organizations and 33 health professionals, activists, and economists — including Nobel Prize laureate Joseph Stiglitz — asking delegates to WHA to support a feasibility study on theRead More →

On Wednesday, 24 May 2017, UACT participated in Knowledge Ecology International (KEI), Oxfam and Stichting Health Action International (HAI) WHA side event on addressing access barriers and affordability challenges for cancer medicines. This event focused on policy options to address the access barriers and affordability challenges for cancer medicines, in conjunction with the Assembly’s consideration of agenda item 15.6 – Cancer prevention and control in the context of an integrated approach. In 2012, cancer was the 2nd leading cause of death in the world (8.2 million); cancer cases are projected to increase from 14.1 million in 2012 to 21.6 million in 2030. Panelists will addressRead More →

On May 24, 2017, the Union for Affordable Cancer treatment and 56 civil society organizations and academic experts called Janet Napolitano, the President of the University of California, and the Board of Regents, “withdraw your efforts to obtain a patent on the prostate cancer drug enzalutamide (brand name Xtandi) in India.”  A PDF copy of the letter is available here: UACT-U-Cal-Xtandi-Patent-India-2017May24 The text of the letter is as follows: Janet Napolitano, University of California, Office of the President, 1111 Franklin Street, Oakland, CA 94607 via email: president@ucop.edu Board of Regents of the University of California, Office of the Secretary and Chief of Staff to the Regents, 1111 Franklin St., 12th floor, Oakland, CA 94607, via email:Read More →